Autophagic pathway and probable mechanism in degradation of mutant α-synuclein in PC12 cells

Chinese Journal of Neurology

Volumn 41, Issue 1, 2008, Pages 51-55

  Liu, Kang Yong ^a   Liu, Chun Feng ^a   Qian, Jin Jun ^a   Cheng, Yan Bo ^a   Yang, Ya Ping ^b   Yang, Fang ^a   Li, Xue Zhong ^a   Wang, Fen ^c   Qin, Zheng Hong ^b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c NONE

Author keywords

synuclein; Autophagocytosis; Parkinson disease; PC12 cells

Indexed keywords

EID: 84860892464     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Terman A, Gustafsson B, Brunk UT. Autophagy, organelles and ageing. J Pathol, 2007, 211: 134-143.
2. Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature, 2004, 432: 1032-1036.
3. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol, 1997, 12: 25-31.
4. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature, 2006, 443: 780-786.
5. Stefanis L, Larsen KE, Rideout HJ, et al. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci, 2001, 21: 9549-9560.
6. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature, 1997, 388: 839-840.
7. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science, 2000, 287; 1265-1269.
8. Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science, 2000, 290: 985-989.
9. 2006, 14: 561-565.
10. Krüger R, Kuhn W, Mtiller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet, 1998, 18: 106-108.
11. Fujiwara H, Hasegawa M, Dohmae N, et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat cell Biol, 2002, 4: 160-164.
12. Hsu LJ, Sagara Y, Arroyo A, et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol, 2000, 157: 401-410.
13. Lotharius J, Barg S, Wiekop P, et al. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem, 2002, 277: 38884-38894.
14. Dalfó E, Gómez-Isla T, Rosa JL, et al. Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. J Neuropathol Exp Neurol, 2004, 63: 302-313.
15. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006, 443: 787-795.
16. Rojo AI, Montero C, Salazar M, et al. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice. Eur J Neurosci, 2006, 24: 1874-1884.
17. Michel PP, Alvarez-Fischer D, Guerreiro S, et al. Role of activity-dependent mechanisms in the control of dopaminergic neuron survival. J Neurochem, 2007, 101: 289-297.
18. Lovell MA, Xiong S, Xie C, et al. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J Alzheimers Dis, 2004, 6: 659-671.
19. Petrucelli L, Dawson TM. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med, 2004, 36: 315-320.
20. Song DD, Shults CW, Sisk A, et al. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol, 2004, 186: 158-172.
21. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science, 2000, 290: 1717-1721.
22. Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science, 2004, 304: 1500-1502.
23. Shimizu S, Kanaseki T, Mizushima N, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol, 2004, 6: 1221-1228.
24. Abeliovich H, Dunn WA Jr, Kim J, et al. Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol, 2000, 151: 1025-1034.
25. Sarkar S, Davies JE, Huang Z, et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem, 2007, 282: 5641-5652.
26. Chan L, Gaston R, Hariharan S. Evolution of immunosuppression and continued importance of acute rejection in renal transplantation. Am J Kidney Dis, 2001, 38: S2-S9.
27. Wellington CL, Singaraja R, Ellerby L, et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem, 2000, 275: 19831-19838.
28. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest, 2005, 115: 2679-2688.
29. Tanaka Y, Engelender S, Igarashi S, et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet, 2001, 10: 919-926.